Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» What Do Analysts Make of Lilly Chief's Stoic Strategy?
What Do Analysts Make of Lilly Chief's Stoic Strategy?
What Do Analysts Make of Lilly Chief's Stoic Strategy?
Submitted by
admin
on November 11, 2010 - 8:56am
Source:
Motley Fool
News Tags:
Eli Lilly
Pharma CEOs
John Lechleiter
Headline:
What Do Analysts Make of Lilly Chief's Stoic Strategy?
Do Not Allow Advertisers to Use My Personal information
